Frank Greenway is an Endocrinology/Metabolic physician affiliated with Pennington Biomedical Research Center. OpenAlex indexes 506 publications with 31,480 citations (h-index 77); ClinicalTrials.gov lists 5 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6400 Perkins Rd
Pennington Center
Baton Rouge, LA 708084124
Telephone
225-763-2578Registry record last updated 15 Nov 2009.
Clinical trials
- Pharmacokinetics of Butyrate Tablet BKR-017
Sponsor: BioKier Inc.
- Chronic Consumption of Vinegar on Visceral Adiposity in Overweight Adults (VAnish)
Sponsor: Pennington Biomedical Research Center
- Effect of Naringenin and Beta Carotene on Energy Expenditure
Sponsor: Pennington Biomedical Research Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Neurocrine BioSciences, Inc.Program year20254 payments$24,186openpaymentsdata.cms.gov ↗
- Novo Nordisk IncProgram year20251 payment
- Dexcom, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2014–2020 per NIH RePORTER. The latest:
- 02/16 Action for Health in Diabetes Extension Study Research Study
Lsu Pennington Biomedical Research Ctr
FY2020$173,320U01DK056990 - 02/16 Action for Health in Diabetes Extension Study Research Study
Lsu Pennington Biomedical Research Ctr
FY2019$213,545U01DK056990 - 02/16 Action for Health in Diabetes Extension Study Research Study
Lsu Pennington Biomedical Research Ctr
FY2018$213,551U01DK056990
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link?
International Journal of Obesity
2020 - Safety and pharmacokinetics of naringenin: A randomized, controlled, single‐ascending‐dose clinical trial
Diabetes Obesity and Metabolism
2019
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”